All Episodes
In the Interim... — 69 episodes
Fairness in Soccer and Clinical Trials
Bias in Stopping Trials Early
A Statistician Reads JAMA: A Futile Issue
Response-Adaptive Randomization in Clinical Trials
REMAP-CAP: The Origin
Fighting Time in Adaptive Trials
ICECAP: The Adaptive Design
Multi-Platform RCT
Sports and Clinical Trials: The 1927 Yankees, 15 Tarzans, and Modern Athletes
AI @ Berry
Drug Development and Sports: The 10-Run Rule and Futility
ICH-E20, Regulators, and False Choices
PANTHER: A Phase 2 International Platform Trial in ARDS
A Visit with Byron Gajewski: KUMC, Innovative Trial Designs, the HOBIT Trial
A Visit with Stephen Senn: Time, Concurrent Controls, and the Bayesian Guidance
Making Sense of Hierarchical Composites
The SNAP Trial with Professors Tong and Davis
Bayesian Borrowing in Phase 3 Trials
The Art of Storytelling with Shaun Cassidy
The Fallacy of Ordinal Endpoints
Mr. Berry Goes to Washington
Platform Trial in Orthopaedic Surgery
A Visit with Michael Harhay
The FDA Bayesian Guidance
Path 2 Parkinson's Prevention with Drs. Simuni and Wendelberger
Statistical Communication
The Rumor of One Trial for Substantial Evidence
Communication for Scientists: A Discussion with Jenny Devenport
Navigating the Arena: Platform Trials
Jumping Hurdles: Interim Analyses for Funding Decisions
Discussion with Kaspar Rufibach
Bayesian Statistics in Clinical trials: The Past, Present, and Future
A Visit with Stroke Neurologist Dr. Jeff Saver
The Saga of the Lecanemab Adaptive Phase II Trial
Teaching Statistics and Data Science through Sports with Dr. Jim Albert
Digital Googols
A Visit with Andrew Thomson
Moving Clinical Trial Goalposts
The Not So Promising Zone Design
A Visit with Dr. Janet Wittes
Bayesian Clinical Trials with Frank Harrell
A Visit with Dr. Derek Angus
The Mystery of Clinical Trial Simulation
Discussions on the ICH E20 Draft Guidance
A Discussion with Michael Proschan on Response-Adaptive Randomization
STEP Statistical Modeling
Bayesian Approach in Clinical Trials
The Time Machine
The Legend of I-SPY 2 - Part B
The Legend of I-SPY 2 - Part A
The STEP Platform with Dr. Eva Mistry and Dr. Jordan Elm
A Statistician reads JAMA
Seamless 2/3 Trial Designs
Spending Alpha
Prof Craig Ritchie: Looking Back at EPAD, moving forward in Alzheimer's Disease
Drug Developers' Lessons from Sports: Regression-to-the-Mean
DSMBs in Adaptive Trials with Roger Lewis
Platform Trial in Psychiatry with Dr. Husseini Manji
Implementing Adaptive Trials
Revisiting Seamless 2/3 Trial for GLP-1 Agonist
I-SPY 2 to GBM AGILE and Beyond
External Data in Clinical Trials
Remembering Jimmie Savage
The Art and Slog of Innovating
Religion, Politics, and Ordinal Outcomes
HEALEY ALS Platform Trial with Dr. Merit Cudkowicz and Dr. Melanie Quintana
FACTS 7.1 Release with Tom Parke
When should you use adaptive design clinical trials?
The Story of Berry Consultants